Oncimmune Holdings plc (ONC) Ordinary 1p
4.00p
(2.27%)
- Add to watchlist
- Create an alert
- This stock can be held in a
4.00p
(2.27%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
4.00p
(2.27%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
172.00p
180.00p
259.00p
£124.42 million
176.00p
165.15p
154.00p
n/a
8.00p (4.76%) Previous:
8.00p
30,564
n/a
3,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/05/2020 | 31/05/2019 |
|---|---|---|
| Revenue (£m) | 0.51 | 0.17 |
| Profit before tax (£m) | (9.78) | (8.55) |
| Adjusted EPS (p): | (13.36) | (12.97) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
Oncimmune inks deal with global pharma firm
20 September 2021 11:24
-
Oncimmune upbeat on three-year lung cancer test study
23 August 2021 15:12
-
Oncimmune inks research deal with Dana-Farber Cancer Institute
23 July 2021 09:44
-
Agreement with pharma company to profile patients
20 September 2021 07:00
-
Block Listing Six Monthly Return
15 September 2021 11:08
-
Three-year follow-up data for the ECLS trial
23 August 2021 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.